Atossa Therapeutics Inc

NASDAQ:ATOS   4:00:00 PM EDT
0.77
0.00 (-0.09%)
7:55:39 PM EDT: $0.77 0.00 (0.61%)
Earnings Announcements

Atossa Therapeutics Reports Q3 Loss Per Share Of $0.06

Published: 11/07/2022 21:59 GMT
Atossa Therapeutics Inc (ATOS) - Atossa Therapeutics Announces Third Quarter 2022 Financial Results and Provides Corporate Update.
Atossa Therapeutics - Qtrly Loss per Share $0.06.
Atossa Therapeutics Says As of September 30, Company Had Cash, Cash Equivalents and Restricted Cash of Approximately $117,477.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.06

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.06

More details on our Analysts Page.